SPARC antibody (AA 52-268)
Quick Overview for SPARC antibody (AA 52-268) (ABIN5027541)
Target
See all SPARC AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 52-268
-
Purification
- Protein A Chromatography
-
Immunogen
- A partial length recombinant SPARC/Osteonectin protein (amino acids 52-268) was used as the immunogen for this antibody.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 2-4 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- PBS containing 0.05 % BSA, PH 7.4
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 4°C, stable for 6 months. For long-term storage, store at -20°C. Avoid repeated freeze and thaw cycles.
-
-
- SPARC (Secreted Protein, Acidic, Cysteine-Rich (Osteonectin) (SPARC))
-
Alternative Name
- SPARC/Osteonectin
-
Background
- SPARC (Secreted protein, acidic, cysteine-rich) is a glycoprotein that binds to collagen type I and other proteins in the extracellular matrix. It is involved in normal tissue remodeling as it regulates the deposition of extracellular matrix, and also plays a role in neoplastic transformation. It modulates interactions between tumoral cells and the peri-tumoral stroma. Homozygous mutations in SPARC give rise to severe bone fragility in humans. SPARC negatively regulates glucose metabolism in hepatocellular carcinoma (HCC). Overexpression of SPARC inhibited glucose uptake and lactate product through downregulation of key enzymes of glucose metabolism.
-
Molecular Weight
- 35 kDa
-
Gene ID
- 6678
-
UniProt
- P09486
-
Pathways
- Autophagy
Target
-